Home - Products - Others - Other Targets - α-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid

α-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid

CAS No. 128253-12-3

α-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid( —— )

Catalog No. M28509 CAS No. 128253-12-3

α-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid was identified as possible dual inhibitors for hLTA4H and hLTC4S enzymes by the computer-aided methodology.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 158 In Stock
5MG 149 In Stock
10MG 220 In Stock
25MG 337 In Stock
50MG 462 In Stock
100MG 619 In Stock
200MG 835 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    α-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    α-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid was identified as possible dual inhibitors for hLTA4H and hLTC4S enzymes by the computer-aided methodology.
  • Description
    α-Cyclopentyl-4-(2-quinolinylmethoxy)benzeneacetic acid was identified as possible dual inhibitors for hLTA4H and hLTC4S enzymes by the computer-aided methodology.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    128253-12-3
  • Formula Weight
    361.43
  • Molecular Formula
    C23H23NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)C(C1=CC=C(OCC2=NC=3C=CC=CC3C=C2)C=C1)C4CCCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • lorvotuzumab

    Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds to CD56 (NCAM1) and can be used to synthesize the antibody-drug conjugate Lorvotuzumab mertansine.

  • D-alpha-Methylbenzyl...

    D-alpha-Methylbenzyl isothiocyanate, an antioxidant and a chiral agent, induces phase II enzyme activity.

  • Sulfamethazine

    Sulfamethazine is a sulfonamide antibacterial.